ANJARIUM BIOSCIENCES
Anjarium is focused on creating a new class of non-viral gene therapies to deliver more predictable, enduring, and inclusionary ways to tackle genetic diseases throughout a patient's lifetime. Combining deep domain expertise in synthetic and natural delivery systems, Anjarium is developing a novel class of bioinspired nanomedicine to address a range of genetic diseases, including those that necessitate very large gene delivery. Anjariumโs versatile platform systematically addresses key deficiencies of viral gene therapies in order to provide benefits to patients that have previously been out of reach.
ANJARIUM BIOSCIENCES
Industry:
Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.anjarium.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
60.35 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Igyxos
Igyxos is a biotech startup developing a new treatment for female and male infertility that works by shifting hormal imbalances.
Imcyse
Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.
New Amsterdam Pharma
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Omega Funds
Omega Funds investment in Series A - Anjarium Biosciences
Abingworth
Abingworth investment in Series A - Anjarium Biosciences
Pfizer Venture Investments
Pfizer Venture Investments investment in Series A - Anjarium Biosciences
Gimv
Gimv investment in Series A - Anjarium Biosciences
Surveyor Capital
Surveyor Capital investment in Series A - Anjarium Biosciences
Swiss Federal Commission for Innovation and Technology
Swiss Federal Commission for Innovation and Technology investment in Grant - Anjarium Biosciences
Key Employee Changes
Official Site Inspections
http://www.anjarium.com
- Host name: 199.60.103.174
- IP address: 199.60.103.174
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto